381 related articles for article (PubMed ID: 32884319)
21. Pustular psoriasis: Molecular pathways and effects of spesolimab in generalized pustular psoriasis.
Baum P; Visvanathan S; Garcet S; Roy J; Schmid R; Bossert S; Lang B; Bachelez H; Bissonnette R; Thoma C; Krueger JG
J Allergy Clin Immunol; 2022 Apr; 149(4):1402-1412. PubMed ID: 34678325
[TBL] [Abstract][Full Text] [Related]
22. Triggering role of focal infection in the induction of extra-palmoplantar lesions and pustulotic arthro-osteitis associated with palmoplantar pustulosis.
Yamamoto T
Adv Otorhinolaryngol; 2011; 72():89-92. PubMed ID: 21865699
[TBL] [Abstract][Full Text] [Related]
23. Treatment of Severe Palmoplantar Pustular Psoriasis With Bimekizumab.
Passeron T; Perrot JL; Jullien D; Goujon C; Ruer M; Boyé T; Villani AP; Quiles Tsimaratos N
JAMA Dermatol; 2024 Feb; 160(2):199-203. PubMed ID: 38054800
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-19 Levels Are Increased in Palmoplantar Pustulosis and Reduced following Apremilast Treatment.
Wolk K; Wilsmann-Theis D; Witte K; Brembach TC; Kromer C; Gerdes S; Ghoreschi K; Reich K; Mössner R; Sabat R
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674793
[TBL] [Abstract][Full Text] [Related]
25. Involvement of Molecular Mechanisms between T/B Cells and IL-23: From Palmoplantar Pustulosis to Autoimmune Diseases.
Fukasawa T; Yoshizaki-Ogawa A; Enomoto A; Miyagawa K; Sato S; Yoshizaki A
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897837
[TBL] [Abstract][Full Text] [Related]
26. Treatment patterns and healthcare resource utilization in palmoplantar pustulosis patients in Japan: A claims database study.
Miyazaki C; Sruamsiri R; Mahlich J; Jung W
PLoS One; 2020; 15(5):e0232738. PubMed ID: 32442204
[TBL] [Abstract][Full Text] [Related]
27. 308-nm excimer light is effective for palmoplantar pustulosis regardless of the presence or absence of focal infection: Single-center real-world experience of treatment for palmoplantar pustulosis.
Niimura Y; Kamata M; Ishikawa T; Nagata M; Ito M; Watanabe A; Egawa S; Uchida H; Hiura A; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Tada Y
J Dermatol; 2024 Jul; 51(7):977-984. PubMed ID: 38483008
[TBL] [Abstract][Full Text] [Related]
28. Possible Efficacy of Vedolizumab, an Anti-α4β7 Integrin Antibody, in Palmoplantar Pustulosis.
Terui H; Moroi R; Masamune A; Aiba S; Yamasaki K
Case Rep Dermatol; 2023; 15(1):22-25. PubMed ID: 36726801
[TBL] [Abstract][Full Text] [Related]
29. Guselkumab for the treatment of palmoplantar pustulosis.
Murakami M
Expert Opin Biol Ther; 2020 Aug; 20(8):841-852. PubMed ID: 32321322
[TBL] [Abstract][Full Text] [Related]
30. Palmoplantar Psoriasis and Palmoplantar Pustulosis: Current Treatment and Future Prospects.
Raposo I; Torres T
Am J Clin Dermatol; 2016 Aug; 17(4):349-58. PubMed ID: 27113059
[TBL] [Abstract][Full Text] [Related]
31. Photodynamic therapy for palmoplantar pustulosis: A case report.
Huang J; Wu M; Wang H
Photodiagnosis Photodyn Ther; 2023 Dec; 44():103829. PubMed ID: 37806607
[TBL] [Abstract][Full Text] [Related]
32. Palmoplantar pustulosis - a cross-sectional analysis in Germany.
Wilsmann-Theis D; Jacobi A; Frambach Y; Philipp S; Weyergraf A; Schill T; Steinz K; Gerdes S; Mössner R
Dermatol Online J; 2017 Apr; 23(4):. PubMed ID: 28541870
[TBL] [Abstract][Full Text] [Related]
33. Interleukin (IL)-8 and IL-36γ but not IL-36Ra are related to acrosyringia in pustule formation associated with palmoplantar pustulosis.
Xiaoling Y; Chao W; Wenming W; Feng L; Hongzhong J
Clin Exp Dermatol; 2019 Jan; 44(1):52-57. PubMed ID: 29896852
[TBL] [Abstract][Full Text] [Related]
34. Dietary habits in Japanese patients with palmoplantar pustulosis.
Serizawa N; Okazaki S; Otsuka Y; Koto M; Okabe K; Ito M; Morita T; Hoashi T; Saeki H; Abe N; Mori M; Okubo Y; Yano Y; Mitsui H; Kanda N
J Dermatol; 2021 Mar; 48(3):366-375. PubMed ID: 33404125
[TBL] [Abstract][Full Text] [Related]
35. Oral alitretinoin treatment in patients with palmoplantar pustulosis inadequately responding to standard topical treatment: a randomized phase II study.
Reich K; Graff O; Mehta N
Br J Dermatol; 2016 Jun; 174(6):1277-81. PubMed ID: 26800106
[TBL] [Abstract][Full Text] [Related]
36. Characteristics and prevalence of plaque psoriasis in patients with palmoplantar pustulosis.
Andersen YMF; Augustin M; Petersen J; Hagenström K; Mallbris L; Burge R; Egeberg A
Br J Dermatol; 2019 Nov; 181(5):976-982. PubMed ID: 30815849
[TBL] [Abstract][Full Text] [Related]
37. Cyclosporin for palmoplantar pustulosis.
Reitamo S; Erkko P; Remitz A
J Autoimmun; 1992 Apr; 5 Suppl A():285-7. PubMed ID: 1503623
[TBL] [Abstract][Full Text] [Related]
38. Successful treatment of palmoplantar pustulosis with isotretinoin.
Wilken R; Sharma A; Patel F; Maverakis E
Dermatol Online J; 2015 Aug; 21(8):. PubMed ID: 26437168
[TBL] [Abstract][Full Text] [Related]
39. Pustulotic arthro-osteitis associated with palmoplantar pustulosis.
Yamamoto T
J Dermatol; 2013 Nov; 40(11):857-63. PubMed ID: 24127744
[TBL] [Abstract][Full Text] [Related]
40. Principal Component Analysis to Differentiate Patients with Palmoplantar Pustulosis from Those with Palmoplantar Pustular Psoriasis.
Kim TH; Kim JS; Kwon JE; Park B; Lee ES
Ann Dermatol; 2022 Feb; 34(1):7-13. PubMed ID: 35221589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
